{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:44:03Z","timestamp":1740109443637,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Organizzazione Toscana Trapianti","award":["2019 - DGRT 641"],"award-info":[{"award-number":["2019 - DGRT 641"]}]},{"DOI":"10.13039\/100012990","name":"Universit\u00e0 degli Studi di Siena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012990","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Galectins are proteins that bind \u03b2-galactosides such as <jats:italic>N<\/jats:italic>-acetyllactosamine present in N-linked and O-linked glycoproteins and that seem to be implicated in inflammatory and immune responses as well as fibrotic mechanisms. This preliminary study investigated serum galectins as clinical biomarkers in lung transplant patients with chronic lung allograft dysfunction (CLAD), phenotype bronchiolitis obliterans syndrome (BOS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>Nineteen lung transplant patients [median age (IQR), 55 (45\u201362) years; 53% males] were enrolled in the study. Peripheral blood concentrations of galectins-1, 3 and 9 were determined with commercial ELISA kits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Galectin-1 concentrations were higher in BOS than in stable LTX patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.0394). In logistic regression analysis, testing BOS group as dependent variable with Gal-1 and 3 as independent variables, area under the receiver operating characteristics (AUROC) curve was 98.9% (NPV 90% and PPV 88.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0003). With the stable LTX group as dependent variable and Gal-1, 3 and 9 as independent variables, AUROC was 92.6% (NPV 100% and PPV 90%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0023). In stable patients were observed an inverse correlation of Gal-3 with DLCO% and KCO%, and between Gal-9 and KCO%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Galectins-1, 3 and 9 are possible clinical biomarkers in lung transplant patients with diagnostic and prognostic meaning. These molecules may be directly implicated in the pathological mechanisms of BOS. The hypothesis that they could be new therapeutic targets in BOS patients is intriguing and also worth exploring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00408-021-00449-3","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T21:54:49Z","timestamp":1620078889000},"page":"281-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Role of Galectins in Chronic Lung Allograft Dysfunction"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-5722","authenticated-orcid":false,"given":"Miriana","family":"d\u2019Alessandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bergantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elda","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice","family":"Perillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Luzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piersante","family":"Sestini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"3","key":"449_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.23736\/S0031-0808.19.03840-0","volume":"62","author":"D Bennett","year":"2020","unstructured":"Bennett D, Lanzarone N, Fossi A, Perillo F, De Vita E, Luzzi L, Paladini P, Bargagli E, Sestini P, Rottoli P (2020) Pirfenidone in chronic lung allograft dysfunction: a single cohort study. Panminerva Med 62(3):143\u2013149. https:\/\/doi.org\/10.23736\/S0031-0808.19.03840-0","journal-title":"Panminerva Med"},{"key":"449_CR2","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.20.06744-0","author":"D Bennett","year":"2020","unstructured":"Bennett D, De Vita E, Fossi A, Bargagli E, Paladini P, Luzzi L, Franchi F, Scolletta S, Sestini P (2020) Outcome of ECMO bridge to lung transplantation: a single cohort study. Minerva Med. https:\/\/doi.org\/10.23736\/S0026-4806.20.06744-0","journal-title":"Minerva Med"},{"issue":"9","key":"449_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.rmed.2015.07.005","volume":"109","author":"P Cameli","year":"2015","unstructured":"Cameli P, Bargagli E, Fossi A, Bennett D, Voltolini L, Refini RM, Gotti G, Rottoli P (2015) Exhaled nitric oxide and carbon monoxide in lung transplanted patients. Respir Med 109(9):1224\u20131229. https:\/\/doi.org\/10.1016\/j.rmed.2015.07.005","journal-title":"Respir Med"},{"issue":"5","key":"449_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00408-015-9767-x","volume":"193","author":"D Bennett","year":"2015","unstructured":"Bennett D, Fossi A, Bargagli E, Refini RM, Pieroni M, Luzzi L, Ghiribelli C, Paladini P, Voltolini L, Rottoli P (2015) Mortality on the waiting list for lung transplantation in patients with idiopathic pulmonary fibrosis: a single-centre experience. Lung 193(5):677\u2013681. https:\/\/doi.org\/10.1007\/s00408-015-9767-x","journal-title":"Lung"},{"issue":"4","key":"449_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/cells10040780","volume":"10","author":"L Bergantini","year":"2021","unstructured":"Bergantini L, d\u2019Alessandro M, De Vita E, Perillo F, Fossi A, Luzzi L, Paladini P, Perrone A, Rottoli P, Sestini P, Bargagli B, Bennett D (2021) Regulatory and effector cell disequilibrium in patients with acute cellular rejection and chronic lung allograft dysfunction after lung transplantation: comparison of peripheral and alveolar distribution. Cells 10(4):780","journal-title":"Cells"},{"issue":"5","key":"449_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","volume":"38","author":"GM Verleden","year":"2019","unstructured":"Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R (2019) Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant 38(5):493\u2013503. https:\/\/doi.org\/10.1016\/j.healun.2019.03.009","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"449_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/modpathol.2012.171","volume":"26","author":"E Ofek","year":"2013","unstructured":"Ofek E, Sato M, Saito T, Wagnetz U, Roberts HC, Chaparro C, Waddell TK, Singer LG, Hutcheon MA, Keshavjee S, Hwang DM (2013) Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol 26(3):350\u2013356. https:\/\/doi.org\/10.1038\/modpathol.2012.171","journal-title":"Mod Pathol"},{"issue":"2\u20133","key":"449_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0304-4165(02)00313-6","volume":"1572","author":"FT Liu","year":"2002","unstructured":"Liu FT, Patterson RJ, Wang JL (2002) Intracellular functions of galectins. Biochim Biophys Acta 1572(2\u20133):263\u2013273. https:\/\/doi.org\/10.1016\/s0304-4165(02)00313-6","journal-title":"Biochim Biophys Acta"},{"issue":"2\u20133","key":"449_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-3083.2007.01986.x","volume":"66","author":"GA Rabinovich","year":"2007","unstructured":"Rabinovich GA, Liu FT, Hirashima M, Anderson A (2007) An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 66(2\u20133):143\u2013158. https:\/\/doi.org\/10.1111\/j.1365-3083.2007.01986.x","journal-title":"Scand J Immunol"},{"issue":"11","key":"449_CR10","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.4049\/jimmunol.1701172","volume":"199","author":"V Sundblad","year":"2017","unstructured":"Sundblad V, Morosi LG, Geffner JR, Rabinovich GA (2017) Galectin-1: a jack-of-all-trades in the resolution of acute and chronic inflammation. J Immunol 199(11):3721\u20133730. https:\/\/doi.org\/10.4049\/jimmunol.1701172","journal-title":"J Immunol"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"103546","DOI":"10.1016\/j.resp.2020.103546","volume":"282","author":"M d'Alessandro","year":"2020","unstructured":"d\u2019Alessandro M, De Vita E, Bergantini L, Mazzei MA, di Valvasone S, Bonizzoli M, Peris A, Sestini P, Bargagli E, Bennett D (2020) Galactin-1, 3 and 9: potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases. Respir Physiol Neurobiol 282:103546. https:\/\/doi.org\/10.1016\/j.resp.2020.103546","journal-title":"Respir Physiol Neurobiol"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"17010","DOI":"10.1038\/cddiscovery.2017.10","volume":"3","author":"JJ Kathiriya","year":"2017","unstructured":"Kathiriya JJ, Nakra N, Nixon J, Patel PS, Vaghasiya V, Alhassani A, Tian Z, Allen-Gipson D, Dav\u00e9 V (2017) Galectin-1 inhibition attenuates profibrotic signaling in hypoxia-induced pulmonary fibrosis. Cell Death Discov 3:17010. https:\/\/doi.org\/10.1038\/cddiscovery.2017.10","journal-title":"Cell Death Discov"},{"issue":"1","key":"449_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2332\/allergolint.O-06-449","volume":"56","author":"Y Nishi","year":"2007","unstructured":"Nishi Y, Sano H, Kawashima T, Okada T, Kuroda T, Kikkawa K, Kawashima S, Tanabe M, Goto T, Matsuzawa Y, Matsumura R, Tomioka H, Liu FT, Shirai K (2007) Role of galectin-3 in human pulmonary fibrosis. Allergol Int 56(1):57\u201365. https:\/\/doi.org\/10.2332\/allergolint.O-06-449","journal-title":"Allergol Int"},{"issue":"2","key":"449_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00408-012-9446-0","volume":"191","author":"N Matsumoto","year":"2013","unstructured":"Matsumoto N, Katoh S, Yanagi S, Arimura Y, Tokojima M, Ueno M, Hirashima M, Nakazato M (2013) A possible role of galectin-9 in the pulmonary fibrosis of patients with interstitial pneumonia. Lung 191(2):191\u2013198. https:\/\/doi.org\/10.1007\/s00408-012-9446-0","journal-title":"Lung"},{"issue":"2","key":"449_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbcan.2015.03.003","volume":"1855","author":"VL Thijssen","year":"2015","unstructured":"Thijssen VL, Heusschen R, Caers J, Griffioen AW (2015) Galectin expression in cancer diagnosis and prognosis: a systematic review. Biochim Biophys Acta 1855(2):235\u2013247. https:\/\/doi.org\/10.1016\/j.bbcan.2015.03.003","journal-title":"Biochim Biophys Acta"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"103323","DOI":"10.1016\/j.resp.2019.103323","volume":"273","author":"D Bennett","year":"2020","unstructured":"Bennett D, Bargagli E, Bianchi N, Landi C, Fossi A, Fui A, Sestini P, Refini RM, Rottoli P (2020) Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis. Respir Physiol Neurobiol 273:103323. https:\/\/doi.org\/10.1016\/j.resp.2019.103323","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"449_CR17","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1038\/s41598-018-22135-w","volume":"8","author":"T Lei","year":"2018","unstructured":"Lei T, Moos S, Klug J, Aslani F, Bhushan S, Wahle E, Fr\u00f6hlich S, Meinhardt A, Fijak M (2018) Galectin-1 enhances TNF\u03b1-induced inflammatory responses in Sertoli cells through activation of MAPK signalling. Sci Rep 8(1):3741. https:\/\/doi.org\/10.1038\/s41598-018-22135-w","journal-title":"Sci Rep"},{"issue":"15","key":"449_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clinbiochem.2014.06.019","volume":"47","author":"R Tan","year":"2014","unstructured":"Tan R, Liu X, Wang J, Lu P, Han Z, Tao J, Yin C, Gu M (2014) Alternations of galectin levels after renal transplantation. Clin Biochem 47(15):83\u201388. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.06.019","journal-title":"Clin Biochem"},{"issue":"1","key":"449_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.transproceed.2014.12.001","volume":"47","author":"MJ Garc\u00eda","year":"2015","unstructured":"Garc\u00eda MJ, Jurado F, San Segundo D, L\u00f3pez-Hoyos M, Iruzubieta P, Llerena S, Casafont F, Arias M, Puente \u00c1, Crespo J, F\u00e1brega E (2015) Galectin-1 in stable liver transplant recipients. Transplant Proc 47(1):93\u201396. https:\/\/doi.org\/10.1016\/j.transproceed.2014.12.001","journal-title":"Transplant Proc"},{"issue":"11","key":"449_CR20","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","volume":"196","author":"BH Culver","year":"2017","unstructured":"Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, McCormack MC, Rosenfeld M, Stanojevic S, Weiner DJ (2017) ATS Committee on Proficiency Standards for Pulmonary Function Laboratories. Recommendations for a standardized pulmonary function report: an official American Thoracic Society Technical Statement. Am J RespirCrit Care Med 196(11):1463\u20131472. https:\/\/doi.org\/10.1164\/rccm.201710-1981ST","journal-title":"Am J RespirCrit Care Med"},{"key":"449_CR21","unstructured":"Human Galectin-1 ELISA Kit (ab260053) | Abcam 2020. https:\/\/www.abcam.com\/human-galectin-1-elisa-kit-ab260053.html"},{"issue":"2","key":"449_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-0037-1618567","volume":"39","author":"A DerHovanessian","year":"2018","unstructured":"DerHovanessian A, Wallace WD, Lynch JP 3rd, Belperio JA, Weigt SS (2018) Chronic lung allograft dysfunction: evolving concepts and therapies. SeminRespirCrit Care Med 39(2):155\u2013171. https:\/\/doi.org\/10.1055\/s-0037-1618567","journal-title":"SeminRespirCrit Care Med"},{"issue":"3","key":"449_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1074\/mcp.M113.030775","volume":"13","author":"F Mundt","year":"2014","unstructured":"Mundt F, Johansson HJ, Forshed J, Arslan S, Metintas M, Dobra K, Lehti\u00f6 J, Hjerpe A (2014) Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma. Mol Cell Proteomics 13(3):701\u2013715. https:\/\/doi.org\/10.1074\/mcp.M113.030775","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"449_CR24","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.18632\/oncotarget.3076","volume":"6","author":"X Zhou","year":"2015","unstructured":"Zhou X, Li D, Wang X, Zhang B, Zhu H, Zhao J (2015) Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness. Oncotarget 6(5):3111\u20133122. https:\/\/doi.org\/10.18632\/oncotarget.3076","journal-title":"Oncotarget"},{"issue":"3","key":"449_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1159\/000491955","volume":"48","author":"ZJ Jiang","year":"2018","unstructured":"Jiang ZJ, Shen QH, Chen HY, Yang Z, Shuai MQ, Zheng S (2018) Galectin-1 restores immune tolerance to liver transplantation through activation of hepatic stellate cells. Cell PhysiolBiochem 48(3):863\u2013879. https:\/\/doi.org\/10.1159\/000491955","journal-title":"Cell PhysiolBiochem"},{"issue":"3","key":"449_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/ajt.12092","volume":"13","author":"AE Morelli","year":"2013","unstructured":"Morelli AE, Thomson AW (2013) Galectin-1, immune regulation and liver allograft survival. Am J Transplant 13(3):535\u2013536. https:\/\/doi.org\/10.1111\/ajt.12092","journal-title":"Am J Transplant"},{"issue":"2","key":"449_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/JLB.3A0317-110R","volume":"103","author":"M Sundqvist","year":"2018","unstructured":"Sundqvist M, Welin A, Elmwall J, Osla V, Nilsson UJ, Leffler H, Bylund J, Karlsson A (2018) Galectin-3 type-C self-association on neutrophil surfaces; the carbohydrate recognition domain regulates cell function. J Leukoc Biol 103(2):341\u2013353. https:\/\/doi.org\/10.1002\/JLB.3A0317-110R","journal-title":"J Leukoc Biol"},{"issue":"6","key":"449_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.intimp.2010.03.001","volume":"10","author":"G Xu","year":"2010","unstructured":"Xu G, Tu W, Xu C (2010) Immunological tolerance induced by galectin-1 in rat allogeneic renal transplantation. Int Immunopharmacol 10(6):643\u2013647. https:\/\/doi.org\/10.1016\/j.intimp.2010.03.001","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"449_CR29","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1681\/ASN.2020030286","volume":"31","author":"S Clotet-Freixas","year":"2020","unstructured":"Clotet-Freixas S, McEvoy CM, Batruch I, Pastrello C, Kotlyar M, Van JAD, Arambewela M, Boshart A, Farkona S, Niu Y, Li Y, Famure O, Bozovic A, Kulasingam V, Chen P, Kim SJ, Chan E, Moshkelgosha S, Rahman SA, Das J, Martinu T, Juvet S, Jurisica I, Chruscinski A, John R, Konvalinka A (2020) Extracellular matrix injury of kidney allografts in antibody-mediated rejection: a proteomics study. J Am SocNephrol 31(11):2705\u20132724. https:\/\/doi.org\/10.1681\/ASN.2020030286","journal-title":"J Am SocNephrol"},{"key":"449_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12898","author":"C Berastegui","year":"2017","unstructured":"Berastegui C, G\u00f3mez-Oll\u00e9s S, S\u00e1nchez-Vidaurre S, Culebras M, Monforte V, L\u00f3pez-Meseguer M, Bravo C, Ramon MA, Romero L, Sole J, Cruz MJ, Rom\u00e1n A (2017) BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients. Clin Transplant. https:\/\/doi.org\/10.1111\/ctr.12898","journal-title":"Clin Transplant"},{"issue":"1","key":"449_CR31","doi-asserted-by":"publisher","first-page":"e000465","DOI":"10.1136\/bmjresp-2019-000465","volume":"6","author":"CT Gan","year":"2019","unstructured":"Gan CT, Ward C, Meachery G, Lordan JL, Fisher AJ, Corris PA (2019) Long-term effect of azithromycin in bronchiolitis obliterans syndrome. BMJ Open Respir Res 6(1):e000465. https:\/\/doi.org\/10.1136\/bmjresp-2019-000465","journal-title":"BMJ Open Respir Res"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.molimm.2019.10.001.Erratum.In:MolImmunol.2020Mar;119:59-63","volume":"116","author":"LC Rodrigues","year":"2019","unstructured":"Rodrigues LC, Kabeya LM, Azzolini AECS, Cerri DG, Stowell SR, Cummings RD, Lucisano-Valim YM, Dias-Baruffi M (2019) Galectin-1 modulation of neutrophil reactive oxygen species production depends on the cell activation state. Mol Immunol 116:80\u201389. https:\/\/doi.org\/10.1016\/j.molimm.2019.10.001.Erratum.In:MolImmunol.2020Mar;119:59-63","journal-title":"Mol Immunol"},{"issue":"1","key":"449_CR33","first-page":"74","volume":"4","author":"CD Gil","year":"2010","unstructured":"Gil CD, Gullo CE, Oliani SM (2010) Effect of exogenous galectin-1 on leukocyte migration: modulation of cytokine levels and adhesion molecules. Int J Clin Exp Pathol 4(1):74\u201384","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"449_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/glycob\/cws128","volume":"23","author":"C Auvynet","year":"2013","unstructured":"Auvynet C, Moreno S, Melchy E, Coronado-Mart\u00ednez I, Montiel JL, Aguilar-Delfin I, Rosenstein Y (2013) Galectin-1 promotes human neutrophil migration. Glycobiology 23(1):32\u201342. https:\/\/doi.org\/10.1093\/glycob\/cws128","journal-title":"Glycobiology"},{"issue":"3","key":"449_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/ac.70.3.3080637","volume":"70","author":"RI Lala","year":"2015","unstructured":"Lala RI, Puschita M, Darabantiu D, Pilat L (2015) Galectin-3 in heart failure pathology\u2014\"another brick in the wall\"? Acta Cardiol 70(3):323\u2013331. https:\/\/doi.org\/10.1080\/ac.70.3.3080637","journal-title":"Acta Cardiol"},{"issue":"5","key":"449_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/01.bor.0000129663.76107.d6","volume":"16","author":"P Reboul","year":"2004","unstructured":"Reboul P, Martel-Pelletier J, Pelletier JP (2004) Galectin-3 in osteoarthritis: when the fountain of youth doesn\u2019t deliver its promises. Curr Opin Rheumatol 16(5):595\u2013598. https:\/\/doi.org\/10.1097\/01.bor.0000129663.76107.d6","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"449_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1432-2277.2008.00705.x","volume":"21","author":"AP FernandesBertocchi","year":"2008","unstructured":"FernandesBertocchi AP, Campanhole G, Wang PH, Gon\u00e7alves GM, Dami\u00e3o MJ, Cenedeze MA, Beraldo FC, de Paula Antunes Teixeira V, Dos Reis MA, Mazzali M, Pacheco-Silva A, C\u00e2mara NO (2008) A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transplant Int 21(10):999\u20131007. https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00705.x","journal-title":"Transplant Int"},{"issue":"3","key":"449_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000314371","volume":"153","author":"S Katoh","year":"2010","unstructured":"Katoh S, Nobumoto A, Matsumoto N, Matsumoto K, Ehara N, Niki T, Inada H, Nishi N, Yamauchi A, Fukushima K, Hirashima M (2010) Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia. Int Arch Allergy Immunol 153(3):294\u2013302. https:\/\/doi.org\/10.1159\/000314371","journal-title":"Int Arch Allergy Immunol"},{"key":"449_CR39","doi-asserted-by":"publisher","first-page":"106929","DOI":"10.1016\/j.intimp.2020.106929","volume":"88","author":"J Yin","year":"2020","unstructured":"Yin J, Li L, Wang C, Zhang Y (2020) Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation. Int Immunopharmacol 88:106929. https:\/\/doi.org\/10.1016\/j.intimp.2020.106929","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"449_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1631\/jzus.B1900051.Erratum.In:JZhejiangUnivSciB.2020Feb.;21(2):178","volume":"20","author":"AB Zhang","year":"2019","unstructured":"Zhang AB, Peng YF, Jia JJ, Nie Y, Zhang SY, Xie HY, Zhou L, Zheng SS (2019) Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation. J Zhejiang Univ Sci B 20(7):605\u2013612. https:\/\/doi.org\/10.1631\/jzus.B1900051.Erratum.In:JZhejiangUnivSciB.2020Feb.;21(2):178","journal-title":"J Zhejiang Univ Sci B"},{"issue":"17","key":"449_CR41","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","volume":"117","author":"Q Zhou","year":"2011","unstructured":"Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, Munn DH, Murphy WJ, Azuma M, Anderson AC, Kuchroo VK, Blazar BR (2011) Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 117(17):4501\u20134510. https:\/\/doi.org\/10.1182\/blood-2010-10-310425","journal-title":"Blood"},{"key":"449_CR42","doi-asserted-by":"publisher","first-page":"105803","DOI":"10.1016\/j.intimp.2019.105803","volume":"75","author":"YM Li","year":"2019","unstructured":"Li YM, Li Y, Yan L, Tang JT, Wu XJ, Bai YJ, An YF, Dai B, Yang CL, Wang LL, Shi YY (2019) Assessment of serum Tim-3 and Gal-9 levels in predicting the risk of infection after kidney transplantation. Int Immunopharmacol 75:105803. https:\/\/doi.org\/10.1016\/j.intimp.2019.105803","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"449_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.intimp.2008.11.013","volume":"9","author":"EL Naka","year":"2009","unstructured":"Naka EL, Ponciano VC, Cenedeze MA, Pacheco-Silva A, C\u00e2mara NO (2009) Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode. Int Immunopharmacol 9(6):658\u2013662. https:\/\/doi.org\/10.1016\/j.intimp.2008.11.013","journal-title":"Int Immunopharmacol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00449-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-021-00449-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00449-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T15:08:09Z","timestamp":1623683289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-021-00449-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1007\/s00408-021-00449-3","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"type":"print","value":"0341-2040"},{"type":"electronic","value":"1432-1750"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was approved by the local ethics committee (Respir1, Prot n 15732, 16 September 2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All subjects gave their written informed consent to the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}